Measuring brain activity in infants using advanced magnetometers
Closed-Loop Triaxial Optically Pumped Magnetometers for High-Sensitivity and High-Bandwidth Magnetoencephalography Measurements of the Developing Brain
This study is looking at how to safely and easily measure brain activity in infants to help us understand their development and any potential brain disorders, using a special device that can pick up tiny signals from their brains.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sandia Corp-Sandia National Laboratories NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project ID | NIH-10848840 on NIH RePORTER |
What this research studies
This research focuses on the non-invasive detection of gamma oscillations in infants, which are crucial for understanding neurodevelopmental and neurodegenerative disorders. By utilizing a cutting-edge magnetoencephalography (MEG) device equipped with optically pumped magnetometers (OPM), the study aims to achieve high sensitivity and bandwidth in measuring these subtle brain signals. The technology allows for precise adjustments of sensors to maximize signal detection, making it particularly suitable for infants. The goal is to enhance the ability to monitor brain activity in young children, providing insights into their cognitive development.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants around six months old who may be at risk for neurodevelopmental disorders.
Not a fit: Patients outside the infant age range or those without any neurodevelopmental concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools for early detection of brain disorders in infants.
How similar studies have performed: Previous research has shown promise in using advanced neuroimaging techniques for brain activity measurement, indicating potential success for this novel approach.
Where this research is happening
Albuquerque, United States
- Sandia Corp-Sandia National Laboratories — Albuquerque, United States (Active)
Researchers
- Principal investigator: Schwindt, Peter D. D. — Sandia Corp-Sandia National Laboratories
- Study coordinator: Schwindt, Peter D. D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.